Free Trial

Jeff Cohen Analyst Performance

Analyst at LADENBURG THALM/SH SH

Jeff Cohen is a stock analyst at LADENBURG THALM/SH SH, covering 10 publicly traded companies across a range of sectors. Over the past year, Jeff Cohen has issued 5 stock ratings, including buy and hold recommendations. While full access to Jeff Cohen's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jeff Cohen's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
15 Last 6 Years
Buy Recommendations
66.67% 10 Buy Ratings
Companies Covered
10 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy66.7%10 ratings
Hold33.3%5 ratings
Sell0.0%0 ratings

Out of 15 total stock ratings issued by Jeff Cohen at LADENBURG THALM/SH SH, the majority (66.7%) have been Buy recommendations, followed by 33.3% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
90.0% of companies on NASDAQ
9 companies
NYSE
10.0% of companies on NYSE
1 company

Jeff Cohen, an analyst at LADENBURG THALM/SH SH, currently covers 10 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
5 companies
50.0%
Consumer Discretionary
5 companies
50.0%

Jeff Cohen of LADENBURG THALM/SH SH specializes in stock coverage within the Medical sector, with additional focus on Consumer Discretionary companies.

Coverage Industries

IndustryPercentage
GAMING
3 companies
30.0%
MED INSTRUMENTS
2 companies
20.0%
MED - DRUGS
1 company
10.0%
MEDICAL SERVICES
1 company
10.0%
MED PRODUCTS
1 company
10.0%
CUSTOM COMPUTER PROGRAMMING SERVICES
1 company
10.0%
DATA PROCESSING & PREPARATION
1 company
10.0%

Jeff Cohen's Ratings History at LADENBURG THALM/SH SH

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
8/28/2025Initiated Coverage$0.99$3.60Buy
Artivion, Inc. stock logo
AORT
Artivion
8/13/2025Downgrade$43.71$38.80Neutral
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
5/5/2025Initiated Coverage$0.63$1.45Buy
CeriBell, Inc. stock logo
CBLL
CeriBell
4/4/2025Initiated Coverage$18.73$32.00Buy
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
2/20/2025Initiated Coverage$21.81$20.00Neutral